Grants Funded
Grant applicants for the 2024 cycle requested a total of nearly $3 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated more than 100 grant applications on the following topics:
The PSF awarded research grants totaling over $650,000 dollars to support more than 20 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
Tissue Engineered Recellularized Small Diameter Vascaular Grafts
Gregory Borschel MD
2003
University of Michigan
Basic Research Grant
Tissue Engineering
A tissue engineered, biocompatible source of small diameter vessels would be of significant clinical benefit to patients requiring vein grafting for free tissue transfer, replantation, lower extremity vascular bypass, or coronary artery bypass. The current practice of autologous vessel harvest is limited by the availability of suitable vessels, operative time, and donor site morbidity. We hypothesize that a chemically acellularized arterial graft seeded with endothelial cells will have mechanical properties suitable for clinical use and remain patent in vivo.
Dr. Borschel is the Chief of Plastic Surgery at Riley Hospital for Children, Indiana University, specializing in pediatric nerve injuries, corneal neurotization, facial paralysis, congenital hand surgery, and microvascular reconstruction. His clinical work focuses on pediatric facial paralysis, nerve injuries, hand surgery and microvascular reconstruction, and he has pioneered corneal neurotization, a treatment for neurotrophic keratopathy, a rare cause of blindness caused by lack of nerve supply to the cornea. His research laboratory focuses on ways to enhance peripheral nerve regeneration, including drug and growth factor delivery, electrical stimulation, and the cellular and molecular mechanisms underpinning neurotrophic keratopathy and corneal neurotization.
Dr. Borschel's clinical work and research have significantly contributed to the field, with over 130 publications and leadership roles in professional societies, including President of the American Society for Peripheral Nerve. His research has received support from various funding agencies, and he has received prestigious awards for his contributions to surgery and academic excellence.